Company Filing History:
Years Active: 2024
Title: Thomas Ondet: Innovator in Cancer Therapeutics
Introduction
Thomas Ondet is a notable inventor based in Val de Reuil, France. He has made significant contributions to the field of cancer therapeutics through his innovative research and development efforts. His work focuses on evaluating the effects of cancer treatments on skin health, which is crucial for improving patient care.
Latest Patents
Thomas Ondet holds a patent for a method that evaluates the efficacy of a composition in reducing the effects of cancer therapeutics on skin. The patent describes an epidermal tridimensional model that exhibits differentiating keratinocytes in a reconstituted stratum corneum model. This model contains a cancer therapeutic at an amount effective to simulate chronic drug exposure. It can be utilized to assess the potential of cancer therapeutics to produce skin-related side effects. Additionally, the method can evaluate the efficacy of a composition in mitigating these effects.
Career Highlights
Thomas Ondet is associated with Johnson & Johnson Consumer Inc., where he applies his expertise in developing solutions for skin-related issues arising from cancer treatments. His work is instrumental in advancing the understanding of how cancer therapies impact skin health.
Collaborations
Some of his notable coworkers include Nicolas Joly-Tonetti and Mario Monshouwer. Their collaborative efforts contribute to the innovative research environment at Johnson & Johnson Consumer Inc.
Conclusion
Thomas Ondet's contributions to the field of cancer therapeutics highlight the importance of innovation in improving patient outcomes. His patented method serves as a valuable tool for evaluating and reducing the adverse effects of cancer treatments on skin health.